Ildong Pharmaceutical Co., Ltd. (KRX:249420)
South Korea flag South Korea · Delayed Price · Currency is KRW
10,990
-90 (-0.81%)
At close: Mar 28, 2025, 3:30 PM KST

Ildong Pharmaceutical Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2016
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2016
Net Income
-4,576-78,928-141,585-99,705-13,019
Upgrade
Depreciation & Amortization
25,93528,31929,54529,31127,663
Upgrade
Loss (Gain) From Sale of Assets
4,908-1,133282.22101.53-2,029
Upgrade
Asset Writedown & Restructuring Costs
9,8573,49219,004550.277,928
Upgrade
Loss (Gain) From Sale of Investments
-1,955-439.72-2,325862.825,222
Upgrade
Loss (Gain) on Equity Investments
273.490.360.541.67-
Upgrade
Stock-Based Compensation
129.79-5.7318.0916.5530.92
Upgrade
Provision & Write-off of Bad Debts
303.04-574.49-85.1-1,142-283.8
Upgrade
Other Operating Activities
1,44924,14056,02060,17816,763
Upgrade
Change in Accounts Receivable
3,634-2,089-1,407-1,85713,386
Upgrade
Change in Inventory
-2,50813,852-15,5326,617-19,036
Upgrade
Change in Accounts Payable
-2,9734,2357,9362,339-3,724
Upgrade
Change in Other Net Operating Assets
-6,185-27,484-5,412-8,639-13,535
Upgrade
Operating Cash Flow
28,293-36,615-53,541-11,36619,366
Upgrade
Operating Cash Flow Growth
-----53.18%
Upgrade
Capital Expenditures
-10,679-13,201-11,873-14,626-14,352
Upgrade
Sale of Property, Plant & Equipment
29,336307.0167.538.1460
Upgrade
Divestitures
79.74--4,142-
Upgrade
Sale (Purchase) of Intangibles
-1,150-1,968-6,401-4,876-2,572
Upgrade
Investment in Securities
12,759-1,601-7,401-26,180-2,240
Upgrade
Other Investing Activities
-344.221,025-842.621,133196.66
Upgrade
Investing Cash Flow
18,458-20,360-26,435-43,368-18,403
Upgrade
Short-Term Debt Issued
15,03084,50023,000141,600198,600
Upgrade
Long-Term Debt Issued
50,00029,25017,00099,40042,000
Upgrade
Total Debt Issued
65,030113,75040,000241,000240,600
Upgrade
Short-Term Debt Repaid
-87,519-48,700-20,000-133,600-207,600
Upgrade
Long-Term Debt Repaid
-3,573-4,850-23,118-10,723-37,532
Upgrade
Total Debt Repaid
-91,092-53,550-43,118-144,323-245,132
Upgrade
Net Debt Issued (Repaid)
-26,06260,200-3,11896,677-4,532
Upgrade
Issuance of Common Stock
-124.83-1,745-
Upgrade
Repurchase of Common Stock
-0.17-1,942---43.34
Upgrade
Dividends Paid
-76.8-160-120--
Upgrade
Other Financing Activities
-1,715-70.4-49.31-0-
Upgrade
Financing Cash Flow
-27,85458,152-3,287104,316-4,576
Upgrade
Foreign Exchange Rate Adjustments
112.18-64.19-177.2440.44-782.09
Upgrade
Net Cash Flow
19,0091,112-83,44050,022-4,395
Upgrade
Free Cash Flow
17,614-49,817-65,413-25,9925,014
Upgrade
Free Cash Flow Growth
-----82.89%
Upgrade
Free Cash Flow Margin
2.86%-8.29%-10.26%-4.64%0.89%
Upgrade
Free Cash Flow Per Share
631.25-1843.01-2483.08-1092.76210.79
Upgrade
Cash Interest Paid
13,53410,4125,6434,0412,711
Upgrade
Cash Income Tax Paid
560.83724.882,524-290.572,439
Upgrade
Levered Free Cash Flow
-6,7075,487-159,418101,154-1,447
Upgrade
Unlevered Free Cash Flow
3,25414,690-153,300107,7521,471
Upgrade
Change in Net Working Capital
17,996-34,927118,531-131,95012,724
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.